---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-006078"
form_type: "8-K"
ticker: "VTGN"
cik: "0001411685"
company_name: "Vistagen Therapeutics, Inc."
filed_at: "2026-02-06T23:59:59+00:00"
generated_at: "2026-05-16T04:04:05.540649+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Vistagen receives Nasdaq deficiency notice for minimum bid price non-compliance

## Summary
- Received Nasdaq notice on Feb 3, 2026 for non-compliance with $1.00 minimum bid price requirement.
- Stock closed below $1.00 for 30 consecutive business days; no immediate effect on listing.
- Must regain compliance by Aug 3, 2026 by having $1.00 closing bid for 10 consecutive days.
- May qualify for a second 180-day compliance period if other listing standards are met.
- Failure to regain compliance could result in delisting from Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001628280-26-006078
- form_type: 8-K
- ticker: VTGN
- cik: 0001411685
- company_name: Vistagen Therapeutics, Inc.
- filed_at: 2026-02-06T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411685/000162828026006078/0001628280-26-006078-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411685/000162828026006078/vtgn-20260203.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-006078
- JSON: https://secwatch.observer/filing/0001628280-26-006078.json
- Plain text: https://secwatch.observer/filing/0001628280-26-006078.txt

## Source-grounded claims
- claim_id: 1ea3a7aa6b4ba0e2657c081f757fee0109a06160
  claim: Vistagen Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  evidence_excerpt: February 3, 2026, Vistagen Therapeutics, Inc. (the “ Company ”) received a letter (the “ Notice ”) from the Listing Qualifications Staff of The Nasdaq Stock Market, LLC (“ Nasdaq ”) indicating that, based upon the closing bid price of the Company’s common stock, par value $0.001 per share (“ Common Stock ”), for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2). The Letter has no immediate effe
  evidence_url: https://www.sec.gov/Archives/edgar/data/1411685/000162828026006078/0001628280-26-006078-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.